Veterinary Medicines Information website

POULVAC LARYNGO LYOPHILISAT POUR SUSPENSION OCULAIRE POUR POULES

Authorised
  • Avian infectious laryngotracheitis virus, strain Salsbury 146, Live

Product identification

Medicine name:
POULVAC LARYNGO LYOPHILISAT POUR SUSPENSION OCULAIRE POUR POULES
Active substance:
  • Avian infectious laryngotracheitis virus, strain Salsbury 146, Live
Target species:
  • Chicken (layer hen)
  • Chicken (for reproduction)
  • Chicken (broiler)
Route of administration:
  • Ocular use

Product details

Active substance and strength:
  • Avian infectious laryngotracheitis virus, strain Salsbury 146, Live
    2.50
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension
Withdrawal period by route of administration:
  • Ocular use
    • Chicken (layer hen)
      • All relevant tissues
        0
        day
    • Chicken (for reproduction)
      • All relevant tissues
        0
        day
    • Chicken (broiler)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD08
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/7456349 4/1984
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 16/09/2024

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025